# Entia Biosciences, Inc.

Entia Biosciences, Inc. is a company headquartered in Sherwood, OR, United States.

## Company overview

- **Legal name:** Entia Biosciences, Inc.
- **Former names in filing history:** Total Nutraceutical Solutions, Inc. (2009-06-12 to 2012-01-30); Total Nutraceutical Solutions (2008-10-29 to 2009-05-20); Generic Marketing Services, Inc. (2007-08-06 to 2008-10-17)
- **Classification:** Company
- **Industry (SIC):** 2833 — Medicinal Chemicals & Botanical Products
- **Headquarters:** Sherwood, OR, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001408299

## About

Entia Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001408299, and its reported industry is Medicinal Chemicals & Botanical Products. In 10-K filed on 2017-05-19, it reported annual revenue of USD 265,466; net income of USD -1,395,782; total assets of USD 439,141 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $265,466 (USD 265,466)
- **Net income:** -$1.4M (USD -1,395,782)
- **Total assets:** $439,141 (USD 439,141)
- **Cash and equivalents:** $76,050 (USD 76,050)
- **Operating cash flow:** -$715,098 (USD -715,098)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $346,910 (USD 346,910)
- **Net income:** -$2.3M (USD -2,260,050)
- **Total assets:** $448,606 (USD 448,606)
- **Cash and equivalents:** $24,133 (USD 24,133)
- **Operating cash flow:** -$536,565 (USD -536,565)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $656,342 (USD 656,342)
- **Net income:** -$2.3M (USD -2,296,591)
- **Total assets:** $870,708 (USD 870,708)
- **Cash and equivalents:** $99,462 (USD 99,462)
- **Operating cash flow:** -$680,284 (USD -680,284)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $314,746 (USD 314,746)
- **Net income:** -$3.1M (USD -3,104,827)
- **Total assets:** $631,094 (USD 631,094)
- **Cash and equivalents:** $36,886 (USD 36,886)
- **Operating cash flow:** -$766,733 (USD -766,733)

## Recent SEC filings

- Form 8-K — filed 2018-09-07 — period 2018-09-06 — FORM 8-K
- Form 8-K — filed 2018-04-20 — period 2018-04-16 — 8-K
- Form 8-K — filed 2018-03-30 — period 2018-03-30 — 8-K
- Form 8-K — filed 2017-12-04 — period 2017-11-28 — 8-K
- Form 10-K — filed 2017-05-19 — period 2016-12-31 — 10-K
- Form DEF 14A — filed 2017-03-02 — period 2017-03-30 — DEF 14A
- Form 8-K — filed 2017-02-24 — period 2017-02-21 — 8-K
- Form 8-K — filed 2016-12-09 — period 2016-12-09 — 8-K
- Form 10-Q — filed 2016-11-14 — period 2016-09-30 — 10-Q
- Form 8-K — filed 2016-11-02 — period 2016-10-27 — 8-K
- Form 10-Q — filed 2016-09-29 — period 2016-06-30 — 10-Q
- Form 8-K — filed 2016-09-28 — period 2016-09-22 — 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/entia-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology